| 1 |
A-dopamine |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
| 2 |
Behavioral: role of dopamine |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
| 3 |
Bromocriptine and other dopamine agonists |
Bromocriptine |
[4] D00633 D00633, D00780 D00780, D03165 D03165, D07870 D07870 💬 |
DRD1 [6] DRD1, DRD2, DRD3, DRD4, DRD5, PRL 💬 |
Alcoholism [15] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
| 4 |
Cerebral dopamine neurotrophic factor |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
| 5 |
Continuous release dopamine agonists |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
| 6 |
Dopamine |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [3] 6 , 7 , 74 💬 |
| 7 |
Dopamine agent |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
| 8 |
Dopamine agonist treatment |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
074 [1] 74 💬 |
| 9 |
Dopamine agonists |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
074 [1] 74 💬 |
| 10 |
Dopamine agonists (pramipexole, ropirinole) |
Dopamine |
[4] D00559 D00559, D00633 D00633, D05575 D05575, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
| 11 |
Dopaminergic agonist + apomorphine |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
| 12 |
Dopaminergic agonists |
- |
- |
- |
- |
006 [1] 6 💬 |
| 13 |
Procedure: embryonic dopamine cell implant surgery |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
| 14 |
Recombinant human cerebral dopamine neurotrophic factor |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
| 15 |
Usual dopaminergic per os treatment |
- |
- |
- |
- |
006 [1] 6 💬 |